vTv Therapeutics Inc - Class A — Liquidità Trimestrale (NASDAQ:VTVT) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 38.27 M32.03 M26.45 M99.49 M89.9 M Totale passività 23.96 M23.13 M24.04 M28.95 M25.46 M Patrimonio netto totale 14.3 M8.9 M2.4 M70.54 M64.44 M Totale passività e patrimonio netto 38.27 M32.03 M26.45 M99.49 M89.9 M Debito totale 0——360 K— Indebitamento netto -36.75 M——-98.14 M—

Notizie

BTIG conferma Buy su vTv Therapeutics, target a 49$

Evercore ISI avvia la copertura su vTv Therapeutics con rating outperform

Evercore ISI initiates vTv Therapeutics stock with outperform rating

BTIG conferma Buy su vTv Therapeutics, target di 49$ mantenuto

BTIG reiterates Buy on vTv Therapeutics stock, $49 target maintained

VTv Stock: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst (NASDAQ:VTVT)

vTv Therapeutics espande l’accordo di licenza per HPP737 con Newsoara Biopharma

vTv Therapeutics expands HPP737 license agreement with Newsoara Biopharma

vTv expands Newsoara license deal for PDE4 inhibitor to global rights

Roth/MKM avvia copertura su vTv Therapeutics con rating Buy

Roth/MKM initiates coverage on vTv Therapeutics stock with Buy rating

This MasTec Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Decoy Therapeutics (NASDAQ:DCOY), e.l.f. Beauty (NYSE:ELF)